163 related articles for article (PubMed ID: 23071607)
1. Pre-diabetes augments neuropeptide Y1- and α1-receptor control of basal hindlimb vascular tone in young ZDF rats.
Novielli NM; Al-Khazraji BK; Medeiros PJ; Goldman D; Jackson DN
PLoS One; 2012; 7(10):e46659. PubMed ID: 23071607
[TBL] [Abstract][Full Text] [Related]
2. Gender-modulated endogenous baseline neuropeptide Y Y1-receptor activation in the hindlimb of Sprague-Dawley rats.
Jackson DN; Milne KJ; Noble EG; Shoemaker JK
J Physiol; 2005 Jan; 562(Pt 1):285-94. PubMed ID: 15513938
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y1 and alpha-1 adrenergic receptor-mediated decreases in functional vasodilation in gluteus maximus microvascular networks of prediabetic mice.
Novielli-Kuntz NM; Lemaster KA; Frisbee JC; Jackson DN
Physiol Rep; 2018 Jul; 6(13):e13755. PubMed ID: 29981203
[TBL] [Abstract][Full Text] [Related]
4. Estrogen modulates the contribution of neuropeptide Y to baseline hindlimb blood flow control in female Sprague-Dawley rats.
Jackson DN; Ellis CG; Shoemaker JK
Am J Physiol Regul Integr Comp Physiol; 2010 May; 298(5):R1351-7. PubMed ID: 20219870
[TBL] [Abstract][Full Text] [Related]
5. Y1- and alpha1-receptor control of basal hindlimb vascular tone.
Jackson DN; Noble EG; Shoemaker JK
Am J Physiol Regul Integr Comp Physiol; 2004 Jul; 287(1):R228-33. PubMed ID: 15044188
[TBL] [Abstract][Full Text] [Related]
6. The effect of aging on adrenergic and nonadrenergic receptor expression and responsiveness in canine skeletal muscle.
Delorey DS; Clifford PS; Mittelstadt S; Anton MM; Kluess HA; Tune JD; Dincer UD; Buckwalter JB
J Appl Physiol (1985); 2012 Mar; 112(5):841-8. PubMed ID: 22194325
[TBL] [Abstract][Full Text] [Related]
7. Alpha-adrenergic and neuropeptide Y Y1 receptor control of collateral circuit conductance: influence of exercise training.
Taylor JC; Yang HT; Laughlin MH; Terjung RL
J Physiol; 2008 Dec; 586(24):5983-98. PubMed ID: 18981031
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y bioavailability is suppressed in the hindlimb of female Sprague-Dawley rats.
Jackson DN; Milne KJ; Noble EG; Shoemaker JK
J Physiol; 2005 Oct; 568(Pt 2):573-81. PubMed ID: 16081487
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y facilitates P2X1 receptor-dependent vasoconstriction via Y1 receptor activation in small mesenteric arteries during sympathetic neurogenic responses.
Gonzalez-Montelongo MDC; Fountain SJ
Vascul Pharmacol; 2021 Feb; 136():106810. PubMed ID: 33181321
[TBL] [Abstract][Full Text] [Related]
10. In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle.
Ekelund U; Erlinge D
Br J Pharmacol; 1997 Feb; 120(3):387-92. PubMed ID: 9031740
[TBL] [Abstract][Full Text] [Related]
11. Type 1 neuropeptide Y receptors and alpha1-adrenoceptors in the neural control of regional renal perfusion.
Eppel GA; Luff SE; Denton KM; Evans RG
Am J Physiol Regul Integr Comp Physiol; 2006 Feb; 290(2):R331-40. PubMed ID: 16195497
[TBL] [Abstract][Full Text] [Related]
12. Is tonic sympathetic vasoconstriction increased in the skeletal muscle vasculature of aged canines?
DeLorey DS; Buckwalter JB; Mittelstadt SW; Anton MM; Kluess HA; Clifford PS
Am J Physiol Regul Integr Comp Physiol; 2010 Nov; 299(5):R1342-9. PubMed ID: 20702803
[TBL] [Abstract][Full Text] [Related]
13. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
Donoso MV; Steiner M; Huidobro-Toro JP
J Pharmacol Exp Ther; 1997 Aug; 282(2):691-8. PubMed ID: 9262332
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y1 receptor vasoconstriction in exercising canine skeletal muscles.
Buckwalter JB; Hamann JJ; Clifford PS
J Appl Physiol (1985); 2005 Dec; 99(6):2115-20. PubMed ID: 16099895
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y and neurovascular control in skeletal muscle and skin.
Hodges GJ; Jackson DN; Mattar L; Johnson JM; Shoemaker JK
Am J Physiol Regul Integr Comp Physiol; 2009 Sep; 297(3):R546-55. PubMed ID: 19571208
[TBL] [Abstract][Full Text] [Related]
16. Adrenergic control of vascular resistance varies in muscles composed of different fiber types: influence of the vascular endothelium.
Behnke BJ; Armstrong RB; Delp MD
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R783-90. PubMed ID: 21677269
[TBL] [Abstract][Full Text] [Related]
17. Muscle metaboreflex activation during dynamic exercise vasoconstricts ischemic active skeletal muscle.
Kaur J; Machado TM; Alvarez A; Krishnan AC; Hanna HW; Altamimi YH; Senador D; Spranger MD; O'Leary DS
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(12):H2145-51. PubMed ID: 26475591
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
19. BIBP3226 inhibits neuropeptide Y and pancreatic polypeptide potentiated neurogenic vasoconstriction.
Barrios VE; Nelson AG; Toombs CF
Life Sci; 1998; 62(6):525-32. PubMed ID: 9464464
[TBL] [Abstract][Full Text] [Related]
20. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
